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Abstract 
We have shown that application of an inhibitor of the enzyme nitric oxide synthase (NOS) effectively suppresses the 
visual responses of relay cells in the dorsal lateral geniculate nucleus (dLGN) of the anaesthetized paralysed cat. Such 
suppression seems to result from a specific reduction in transmission via     acid (NMDA) 
receptors, since iontophoretic application of the inhibitor of NOS selectively and in a dose-dependent manner 
decreased the responses to exogenously applied NMDA. Responses to other exogenously applied amino acid 
agonists, such as quisqualate (Quis), kainate (Kain) and α-amino-3-hydroxy-5-5-methyl-4-isoxazole-propionic acid 
(AMPA) were largely unaffected. Furthermore, the excitatory action of acetylcholine (ACh), normally co-localized 
with NOS in axonal terminals within the dLGN arising from the brainstem, was also unaffected. Unlike some other 
actions of nitric oxide (NO), this role seems not to involve an increase in production of cyclic guanosine-3',5'-mono-
phosphate (cGMP), since application of the membrane permeable cGMP analogue 8-bromo-cGMP did not alter the 
suppressive effect of NOS inhibitors on either visual or NMDA evoked responses. We conclude that the normal 
function of NO at this level of the visual system is permissive, allowing full expression of NMDA mediated visually 
elicited information. 
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Nitric oxide (NO) is a highly diffusible gaseous compound formed by the calcium dependent action of 
the enzyme nitric oxide synthase (NOS) on the amino acid L-arginine (L-Arg) (for a review see 
Garthwaite, 1991; Snyder and Bredt, 1991; Moncada et al., 1991). This compound is now widely 
regarded as a transmitter substance within the mammalian CNS, where its mode of action has previously 
been suggested to be retrograde, i.e. formed in post-synaptic cells, but diffusing to work upon pre-
synaptic elements, probably by increasing levels of cyclic guanosine-3’,5’-mono-phosphate (cGMP) 
(Garthwaite et al., 1988, 1989; Bredt and Snyder, 1989). Until now, a role in long-term potentiation 
(LTP) (Bohme et al., 1991; Haley et al., 1992; Schuman and Madison, 1991; Izumi et al., 1992) and 
long-term depression (LTD) (Shibuki and Okada, 1991) or a role in neurotoxicity/neuroprotective 
mechanisms (Dawson et al., 1991, 1993; Lei et al., 1992; Lipton et al., 1993) have been the favoured 
hypotheses, each involving a modulation of excitatory amino acid neurotransmission. Our most recent 
evidence, however, offers an alternative mechanism of action, at least within the dorsal lateral geniculate 
nucleus (dLGN) of the cat, a primary sensory nucleus within the visual system. In this nucleus incoming 
visual information from the retina is modified by both visual and non-visual inputs, en route to the visual 
cortex. It has been shown that visual input is heavily dependent upon N-methyl-D-aspartic acid (NMDA) 
mediated excitation (Kemp and Sillito, 1982; Sillito et al., 1990). At this site, NO is formed only in 
presynaptic elements, in axonal terminals of the cholinergic input from the brainstem (Bickford et al., 
1993). Traditionally this input ,has been thought to be part of the system of arousal, enhancing the signal-
to-noise ratio of the visual information passing to the cortex (Singer, 1977; Sherman and Koch, 1986). 
The role of NO in this pathway seems to be crucial, since we have shown that the visual responses of 
dLGN cells are essentially dependent upon the production of NO at this level. Application of inhibitors of 
NOS to dLGN cells markedly suppresses all visual responses (Cudeiro et al., 1994a), and this role for NO 
involves the activation of NMDA receptors on the post-synaptic cell (Cudeiro et al., 1994b). Here we 
expand our hypothesis to examine the selectivity of this action, and address some possible mechanisms.  
Methods 
Experiments were carried out on 15 adult cats anaesthetized with a mixture of N2O (70%) 02 (30%) 
and halothane (0.1-5%). The level of halothane was varied as necessary over the course of the experiment 
with 5% at the induction of anaesthesia, 2-4% during surgical procedures, and a subsequent long-term 
maintenance level of 0.1-0.5% after paralysis with gallamine triethiodide (40 mg initial dose, then 10 
mg/kg/hr). End-tidal CO2 levels, ECG waveform, intersystolic interval and the frequency of spindles in 
the EEG were monitored continuously through the experiment. The rate and depth of artificial ventilation 
was adjusted to maintain end-tidal CO2 at 3.8-4.2%; the level of halothane was chosen to give a state of 
light anaesthesia. Once a stable state was reached, any variation in the monitored parameters 
commensurate with a change in the depth of anaesthesia was immediately compensated for by adjusting 
the level of halothane. All wounds margins were treated with s.c. injections of procaine hydrochloride, 
and the ear bars of the stereotaxic apparatus were coated with antiseptic lignocaine hydrochloride gel. The 
eyes were treated with atropine methonitrate and phenylephrine hydrochloride and protected with plastic 
contact lenses.  
Seven barrelled micropipettes were used for recording single-unit activity and the iontophoretic 
application of drugs. Each drug barrel of the electrode contained a selection of the following: 3 M NaCl 
for extracellular recording, L-Arg (10 mM, pH 6.0), physiological substrate for NOS; NG-nitro-L-arginine 
(L-NOArg, 10 mM, pH 6.0) a competitive inhibitor of NOS; quisqualate (quis, 25 mM, pH 8.0); α-amino-
3-hydroxy-5-5-methyl- 4-isoxazole-propionic acid (AMPA, 15 mM, pH 8); kainate (kain, 0.1 M, pH 8); 
NMDA (0.1 M, pH 8); acetylcholine (ACh, 0.2 M, pH 4); 8-bromo-cGMP (10 mM, pH 4.5) and 
Pontamine sky blue (2% w/v in 0.5 M sodium acetate) for histological reconstruction.  
For each cell, after classification, visual responses were tested quantitatively before, during and after 
application of L-NOArg, alone or in combination with L-Arg. Visual stimuli, usually bars or gratings, 
were selected in order to engage different synaptic pathways, both from retina and visual cortex to dLGN, 
and to invoke visually elicited intrageniculate inhibitory mechanisms (for a review see Sillito, 1992). 
More details about visual stimulation and experimental procedures are given elsewhere (Sillito et al., 
1993). Pulsatile application of excitatory amino acids were also quantitatively examined in the same 
manner.  
Results 
We have tested the effect of blockade of NO production on a population of 51 dLGN cells. In terms of 
cell type, this population included X and Y cells of both ON and OFF subtypes, and therefore included 
representatives of all major relay cell types found in the A laminae of the cat dLGN. We observed no 
differences in the responses outlined below between the various cell types encountered. Figure 1 
illustrates the effect of blockade of NO production on the responses of an ON X cell, stimulated with 
moving light bars of different lengths, [thus effectively engaging both retinally and cortically driven 
synaptic mechanisms (see Sillito, 1992)]. It is clear that at all bar lengths, responses are markedly reduced 
by application of L-NOArg [Fig. l(a)]. In Fig. l(b), application of L-Arg is shown to be without effect 
when applied alone, but, in combination with L-NOArg [Fig. l(c)] the inhibitory effects of L-NOArg are 
completely reversed. In 32 out of 34 cells visual responses were effectively decreased by application of L-
NOArg, with a mean reduction of 60% (f 8%, SEM). Recovery from the effect of the NOS inhibitor 
routinely took between 8 and 15 min, in keeping with the known dissociation kinetics of the enzyme 
(Klatt et al., 1994).  
The effect of application of L-NOArg upon NMDA mediated excitation was similar to that on visual 
responses. This is shown in Fig. 2. In all cells tested, L-NOArg clearly inhibited the responses to 
application of NMDA, although it has been previously demonstrated that L-NOArg itself has no direct 
effect on NMDA receptors (Dawson et al., 1991). The effect of different application currents of L-NOArg 
upon NMDA mediated responses are shown in Fig. 2(a), where the mean responses of a population of 25 
cells are illustrated. From this histogram, it is obvious that L-NOArg decreased the dLGN cell responses 
in a dose-dependent manner. Figure 2(b) shows the responses of an ON Y cell to a range of application 
currents of NMDA (solid line). Application of L-NOArg (dashed line) almost completely suppressed the 
excitatory responses, an effect which was reversed by concurrent application of L-Arg (dot-dashed line), 
suggesting competitive inhibition of NOS. L-Arg applied alone had no effect on visual evoked responses 
(dotted line).  
The selectivity of these suppressive effects is shown in Fig. 3. In this histogram, the responses of 
some 12 cells to a range of excitatory compounds are compared (solid bars). Application of L-NOArg 
(hatched bars) effectively and selectively reduced the responses to NMDA. Responses to the other amino 
acids, quis, AMPA and kain although affected were much less reduced, but did not reflect the action of a 
non-specific excitatory amino acid inhibitor since the responses to the non-amino-acid excitant ACh were 
equally, but marginally. affected. In fact, the inset to the figure reveals that there was a degree of non-
specific suppression of background activity, which can clearly account for the small effects seen on quis, 
AMPA, kain and ACh.  
 
 
 
Fig. 1. (a) Tuning curve for the responses (spikes/set, y-axis) of an ON X dLGN cell to moving light bars of different length 
(degrees in length, x-axis). Solid line represents the magnitude of control visual responses in the absence of pharmacological 
intervention. Dashed line gives the responses during continuous iontophoretic application of 80 nA of L-NOArg. (b) The solid line 
represents the recovery of responses from drug application in (a), and the dashed line the subsequent set of responses measured 
during continuous application of 80 nA of L-Arg. (c) Again the solid line represents recovery from the previous drug application 
and the dashed line the responses during continuous application of both L-NOArg and L-Arg, using application currents as above. 
Responses were measured in spikes/set ± SEM during the visual response.  
We have addressed one possible mechanism of action of this NMDA specific suppressive effect of 
NOS inhibition, and this is illustrated in Fig. 4. The histogram in Fig. 4(a) gives the mean responses of 10 
cells, from left to right: to NMDA alone; NMDA in the presence of L-NOArg; in the presence of L-
NOArg + L-Arg; and finally, in the presence of L-NOArg + 8-bromo-cGMP. Clearly, once more, L-Arg 
completely blocked the suppressive effects of L-NOArg, while 8-bromo-cGMP alone produced very 
small and variable effects (data not illustrated) and was unable to alter the effect of LNOArg. In Fig. 4(b), 
the comparable effects on visual responses are shown. The pattern of observed effects was remarkably 
similar-again L-NOArg suppressed visual responses, and was reversed by concurrent application of L-
Arg, while application of 8-bromo-cGMP was unable to alter this suppression. This lack of an observable 
effect of 8-bromo-cGMP is in keeping with other published work (Tanaka et al., 1993).   
 
 
 
Fig. 2. (a) Histogram comparing the responses of a population of 25 dLGN cells to pulsatile iontophoretic application of NMDA (90 
nA), in the absence of (0 nA) and during continuous application of 20, 40 and 80 nA L-NOArg (left to right). Responses are given 
as mean ± SEM, pulse length 3 sec. (b) Dose-response curves for an ON Y cell to incremental doses of NMDA in the range 0-130 
nA, alone (solid line), in the presence of L-NOArg (80 nA, dashed line), L-Arg (80 nA, dotted line) and both L-NOArg and L-Arg 
(80 nA each, dot-dashed line).  
 
 
 
Fig. 3. Histogram comparing the responses of dLGN cells to a range of excitatory compounds before (solid bars) and during 
application of L-NOArg (80 nA, hatched bars). Iontophoretic doses producing approximately similar degrees of excitation were 
compared on a population of 12 cells, and results are given as mean number of spikes/set ± SEM. Bottom figure: spontaneous 
activity of the same cells before and during application of L-NOArg-note the change in scale of the y-axis.  
 
 
 
 
 
 
Fig. 4. (a) Histogram documenting the mean responses of a population of 10 dLGN cells to NMDA alone, NMDA + LNOArg, 
NMDA + L-NOArg + L-Arg and NMDA + LNOArg + 8-bromo-cGMP (left to right: NMDA, 90 nA; L-NOArg and L-Arg, 80 nA; 
S-bromo-cGMP, 80 nA). Increased 8-bromo-cGMP currents to 120 nA were similarly without effect (data not shown). (b) Similar 
histogram to (a) in this case substituting the NMDA driven discharge for a visually elicited excitatory response. The visual response 
was produced by a spot of light of optimum diameter flashed over the receptive field centre. Responses are mean f SEM.  
Discussion 
We have shown, both here and in previously published work (Cudeiro et al., 1994a), that the nature of 
the visual stimulus, and by extension the synaptic pathway involved, is not critical for the action of NO 
we report. Instead, with the data presented above, the evidence favours the view that the normal action of 
NO in this system is permissive, allowing complete expression of NMDA-evoked excitation from 
whichever source. Interestingly previously published work, almost without exception, from other, non-
sensory, neural systems, has localized NOS within the post-synaptic cell bodies, suggesting that at least 
one mode of action is upon pre-synaptic elements, acting by diffusion to alter levels of transmitter release 
(Garthwaite, 1991).  
The previous hypotheses regarding the mode of action and physiological role of NO have been 
exclusively based upon this anatomical localization. However, the NOS system within the cat dLGN, we 
believe, is so far unique. Here NOS is exclusively localized within presynaptic axonal terminals, not cell 
somata; in fact only within the terminals of axons arising from cholinergic cells with somata located 
within the parabrachial region of the brainstem (Bickford et al., 1993). Thus the possibility exists of a 
novel system of N.9 action at this locus. The actions we have outlined above are significantly different 
from many of the previously held views of NO function at the cellular level (Arnold et al., 1977; Miki et 
al., 1977; Deguchi and Yoshioka, 1982; Garthwaite et al., 1988, 1989; Bredt and Snyder, 1989; Manzoni 
and Bockaert, 1993; Tanaka et al., 1993). Simply put, previous evidence has favoured two possible 
modes of action for NO. Firstly, an action mediated by increased production of presynaptic cGMP 
thereby increasing excitatory transmitter release and, by extension as we have shown above, increasing 
post-synaptic cell activity [but supporting a role in NMDA mediated neurotoxicity (see Dawson et al., 
1991, 1993)]. However, within the cat dLGN we have been unable to alter the effect of blockade of NO 
production using a cGMP analogue, and are therefore reluctant to accept that here at least this mechanism 
is in operation. Secondly, it has been suggested that NO may act directly upon the NMDA receptor 
(Aizenman et al., 1989; Lei et al., 1992; Lipton et al., 1993) to alter the configuration of the molecule, 
and thereby to decrease the effectiveness of endogenous and, of course exogenous agonists of NMDA 
receptors, implying a neuroprotective function.  
Our data cannot directly address this issue, since the neuroprotective actions outlined are not activated 
in our in vivo experimental design, which utilizes only normal physiological or pharmacological, rather 
than pathological, mechanisms. In isolated in vitro slices of sensory CNS, Pape and Mager (1992) have 
suggested one further mode of action, in which NO modulates the activity of the post-synaptic cation 
current Ih resulting in a shift from the burst mode of firing associated with sleep to the tonic mode 
associated with arousal. Once more, this is certainly not a mechanism easily amenable to study within our 
anaesthetized in vivo preparation. Instead, our results with application of NMDA clearly suggests a more 
fundamental action, also post-synaptic, by which the normal function of the presynaptic location of NOS 
gates or permits complete expression of the retinal input to dLGN relay cells, via NMDA receptors. 
Obviously, the location of the enzyme in the dLGN, within presynaptic axonal terminals, suggests a very 
specific physiological role, related in function to that of the cholinergic action with which it shares an 
anatomical location. Acetylcholine is released from presynaptic terminals in response to incoming action 
potentials, the rate of which are considered to be related to the level of arousal (Singer, 1977; Sherman 
and Koch, 1986; Steriade and Llinas, 1988). It therefore seems likely that release of NO, produced in a 
calcium-dependent manner, may follow such synaptic drive, as presynaptic calcium levels alter. Rising 
levels of NO may then affect post-synaptic cell mechanisms both by the action we have described upon 
NMDA receptors, or an action on Ih (Pape and Mager, 1992). Although we have no direct evidence for 
such hypotheses, it is pertinent to note that in our hands application of L-Arg alone is without effect, 
suggesting that the available NOS is unable to utilize increased levels of substrate, perhaps requiring 
increased intracellular Ca2+ for higher production. To address this issue directly, we must attempt to apply 
NO, or an analogue of NO, to dLGN cells directly, work which is currently in progress in our laboratory.  
To conclude, we believe our data supports the view that within the dLGN, the NO system represents 
an essentially continually active, but possibly modifiable, system for the gating of NMDA mediated 
excitation; required for normal physiological visual function, but with a role in neuropathology not 
excluded.  
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